What’s new on the treatment of pedophilia and hebephilia?

Introduction Paraphilias constitute a set of psychiatric conditions that are often chronic and require combination treatment approaches, such as pharmacotherapy psychotherapy. Sexual interest toward prepubescents pubescents (pedophilia hebephilia) is frequently identified in criminal settings, within numerous child sexual abuse pornography offenses. The high prevalence rates negative consequences these acts, causing distress multiple important areas health functioning, reveal the importance preventing offenses clinical social matter. Secondary prevention programs, which provide support for those with paraphilia disorders before sexually abusive behaviors legal system involvement, show ethically socially necessary. Objectives We aim to discuss bring insights into knowledge on pedophilia hebephilia treatments fields psychotherapy well pharmacologic strategies. Methods present non-systematic review updated literature this subject from data found PubMed PsycInfo databases. Results Preliminary results recent works at-risk individuals willing seek without external pressure system, report benefits early treatments. Most studies gonadotropin-releasing hormone agonists reduce risk men pedophilia. An injectable form has shown lower 2 weeks after initial injection, suggesting its use rapid-onset option. Cyproterone acetate medroxyprogesterone other anti-androgen drugs inhibit hypersexual behavior, side effects be considered. androgen deprivation greater effect fantasies, urges, behaviours paraphilic patients. Cognitive-behavioural shows best should soon initiated all Biomolecular revealed serotonin prolactin arousal, being SSRIs used first younger patients, particularly less severe cases. Conclusions Evidence-based randomized trials paedophilic hebephilic lacking. These current numbers need widespread implementation primary secondary initiatives, go beyond repeated offense. There further research using controlled, examine effectiveness offender including psychotherapeutic interventions. development more specific, effective, better-tolerated medications recognized program worthy government pharmaceutical industry sources. Disclosure Interest None Declared